1. Home
  2. NEUP vs ACCL Comparison

NEUP vs ACCL Comparison

Compare NEUP & ACCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NEUP

Neuphoria Therapeutics Inc.

HOLD

Current Price

$3.88

Market Cap

23.1M

Sector

N/A

ML Signal

HOLD

Logo Acco Group Holdings Limited Ordinary Shares

ACCL

Acco Group Holdings Limited Ordinary Shares

HOLD

Current Price

$2.23

Market Cap

26.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEUP
ACCL
Founded
1996
2009
Country
United States
Hong Kong
Employees
8
22
Industry
Professional Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
23.1M
26.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NEUP
ACCL
Price
$3.88
$2.23
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$21.00
N/A
AVG Volume (30 Days)
206.9K
24.4K
Earning Date
05-23-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$17.13
Revenue Growth
N/A
N/A
52 Week Low
$3.19
$1.23
52 Week High
$21.31
$5.00

Technical Indicators

Market Signals
Indicator
NEUP
ACCL
Relative Strength Index (RSI) 53.40 77.40
Support Level $3.91 $1.31
Resistance Level $4.31 $2.34
Average True Range (ATR) 0.24 0.11
MACD 0.09 0.02
Stochastic Oscillator 72.83 79.57

Price Performance

Historical Comparison
NEUP
ACCL

About NEUP Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

Share on Social Networks: